1-3 of 3
Zhen-xing Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Refractory B-ALL Patient Relapsed with Leukemia Cells Expressing CD19 and Anti-CD19 CAR Gene 14 Days after CR from Anti-CD19 CAR T-Cell Therapy

Liu Meijing, Rui Cui, MD, Juan Mu, Ji-jun Yuan, Nan Mou, Zhen-xing Yang, Jiang Yan-yu, Meng Juanxia, QI Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5124.
https://doi.org/10.1182/blood-2019-126398
Published: 2019
Journal Articles

Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Jia Wang, Ji-jun Yuan, Juan Mu, Qing Li, Nan Mou, Zhen-xing Yang, Wei Li, Lanfang Li, Peiqi Zhao, Xianhuo Wang, Yedi Pu, Huilai Zhang, MD, Qi Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5346.
https://doi.org/10.1182/blood-2019-127896
Published: 2019
Journal Articles

Anti-CD19-CAR T-Cell from Patients Relapsed after Allo-HSCT with a Low Level of Donor Chimerism Restored to Complete Donor Chimerism: Successful Cases and Analysis

Qing Li, Juan Mu, Zhen-xing Yang, Nan Mou, Jia Wang, Ji-jun Yuan, Yanyu Jiang, Meng Juanxia, Qi Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5628.
https://doi.org/10.1182/blood-2019-127850
Published: 2019